콘텐츠로 건너뛰기
Merck
모든 사진(1)

주요 문서

450960

Sigma-Aldrich

Lutetium(III) chloride

anhydrous, powder, 99.99% trace metals basis

동의어(들):

Lutetium chloride, Lutetium trichloride

로그인조직 및 계약 가격 보기


About This Item

Linear Formula:
LuCl3
CAS Number:
Molecular Weight:
281.33
EC Number:
MDL number:
UNSPSC 코드:
12352302
PubChem Substance ID:
NACRES:
NA.23

Grade

anhydrous

Quality Level

분석

99.99% trace metals basis

형태

powder

반응 적합성

reagent type: catalyst
core: lutetium

불순물

≤150.0 ppm Trace Rare Earth Analysis

mp

905 °C (lit.)

density

3.98 g/mL at 25 °C (lit.)

SMILES string

Cl[Lu](Cl)Cl

InChI

1S/3ClH.Lu/h3*1H;/q;;;+3/p-3

InChI key

AEDROEGYZIARPU-UHFFFAOYSA-K

애플리케이션

Lutetium(III) chloride can be used:
  • As a precursor to synthesize chiral bridged lutetium catalyst for asymmetric hydroamination.
  • As a starting material to prepare doped lutetium oxide nanophosphors.
  • To fabricate scintillation detectors such as lutetium aluminum garnet (LuAG).

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

개인 보호 장비

dust mask type N95 (US), Eyeshields, Gloves


가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Development of new technologies for the manufacturing of nanocrystalline scintillation materials
Nikoloz V Jalabadze, et al.
IEEE transactions on nuclear science, 55, 1514-1522 (2008)
A Chiral-Bridged Aminotroponiminate Complex of Lutetium as Catalyst for the Asymmetric Hydroamination
Nils Meyer, et al.
Organometallics, 25, 4179-4182 (2006)
Sanjay Kumar Saxena et al.
Cancer biotherapy & radiopharmaceuticals, 32(10), 364-370 (2017-12-22)
The primary objective of this investigation is the development of a strategy for the synthesis of polyhydroxamic acid (PHA)-grafted cellulose film, its characterization, and evaluation of its usefulness for the preparation of
Swayamjeet Satapathy et al.
Clinical nuclear medicine, 45(9), e393-e399 (2020-07-01)
Advanced inoperable/metastatic neuroendocrine tumors (NETs) pose a therapeutic challenge with limited treatment options. Peptide receptor radionuclide therapy (PRRT), being specific in targeting the somatostatin receptors, is a promising and viable option in this setting. In this study, we intended to
Swayamjeet Satapathy et al.
Nuclear medicine communications, 41(7), 629-635 (2020-05-07)
Peptide receptor radionuclide therapy (PRRT) has been shown to be useful in inoperable/metastatic medullary thyroid carcinoma (MTC). However, the role of concomitant PRRT and low-dose capecitabine therapy has not yet been studied in these patients. This study was conducted to

문서

Rare earth elements are vital in everyday life worldwide: catalysts in cars, colors in screens, magnets in electronics. Essential for modern living.

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.